FN1 and soft tissue neoplasm: As RMS is a skeletal muscle−derived soft tissue tumor, it is not surprising that muscle differentiation and its dysregulation are major contributors to FN-RMS tumorigenesis and progression, which are indicated by the differentially expressed fGCN modules 18 and 46.